US Patent 10253080 Glucagon-like-peptide-2 (GLP-2) analogues
Patent 10253080 was granted and assigned to Zealand Pharma A/S on April, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+340 characters)
Article
Patent abstract
GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102530800
Date of Patent
April 9, 2019
0Patent Application Number
159502350
Date Filed
April 11, 2018
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102530800
Date of Patent
April 9, 2019
0Patent Application Number
159502350
Date Filed
April 11, 2018
0Patent Primary Examiner
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10253080 Glucagon-like-peptide-2 (GLP-2) analogues
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10253080
Date of patent
April 9, 2019
Patent application number
15950235
Date Filed
April 11, 2018
Patent primary examiner
Find more entities like US Patent 10253080 Glucagon-like-peptide-2 (GLP-2) analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
